CDMRP Prostate Cancer Research Program
The FY26 Defense Appropriations Act provides funding for the PCRP to support innovative, high-impact research with clinical relevance that will eliminate death and suffering from prostate cancer. As part of the DHA R&D-MRDC, the CDMRP is the program office managing these anticipated FY26 funding opportunities.
The PCRP provides the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY26 funding opportunities.
Applications submitted to the FY26 PCRP must address one or more of the following overarching challenges:
- Improve overall health, wellness and survivorship for those impacted by prostate cancer
- Develop new treatments or improve existing therapies to improve outcomes for patients with lethal prostate cancer
- Enhance clinical care for all patients with prostate cancer
- Define the biology of prostate cancer progression to lethal prostate cancer to reduce death
Four award mechanisms are available:
- Data Science Award
- Early Investigator Research Award
- Idea Development Award
- Physician Research Award
The PCRP requres submission of a letter of intent prior to full application submission.